New stent aims to keep leg arteries open longer

NCT ID NCT07122167

Recruiting now Disease control Sponsor: MDCECRO LLC Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is checking how safe and effective the ZENFLEX Pro drug-eluting stent is for people with peripheral artery disease (PAD) — narrowed or blocked arteries in the leg. About 153 adults with leg pain or sores will get the stent and be followed for a year. The main goal is to see if the artery stays open without needing another procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: drug-eluting stent (coated with antiproliferative drug)
What this could lead to: If successful, this could confirm that the ZENFLEX Pro stent safely keeps leg arteries open longer, reducing the need for repeat procedures.
What could go wrong: This is an observational registry, not a randomized trial, so results may be less definitive. The stent may still fail to prevent re-narrowing in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERIAL DISEASE

Contacts and locations

Locations

Cardiovascular
RECRUITING

Chrzanów, Chrzanow, 32-500, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.